Abiopharma

🔍 REEVE GRAHAM D. (Executive)

Company: U S PHYSICAL THERAPY INC /NV (USPH)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Sold 762 shares of Common Stock at $78.0 per share (Direct)
  Date: 2026-08-20 | Code: F | equity_swap_involved: false | shares_owned_after: 28,554.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting.
• F2: Includes 17,488 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,948 shares will vest on November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.